🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/05/2013 | 44,45 | 44,56 | 42,95 | 44,25 | -0,77% | 3,63% | 12.536.910 |
| 15/05/2013 | 44,59 | 45,10 | 44,33 | 44,59 | +0,17% | 1,71% | 13.831.294 |
| 14/05/2013 | 44,01 | 44,63 | 43,89 | 44,51 | +1,04% | 1,67% | 14.057.767 |
| 13/05/2013 | 43,74 | 44,11 | 43,59 | 44,06 | +0,48% | 1,20% | 10.738.018 |
| 10/05/2013 | 43,45 | 43,85 | 43,41 | 43,85 | +1,01% | 1,01% | 14.592.142 |
| 09/05/2013 | 43,18 | 43,53 | 42,89 | 43,41 | +1,11% | 1,48% | 14.856.134 |
| 08/05/2013 | 43,05 | 43,51 | 42,91 | 42,93 | -0,62% | 1,40% | 19.187.098 |
| 07/05/2013 | 43,03 | 43,23 | 42,82 | 43,20 | +0,64% | 0,93% | 15.226.078 |
| 06/05/2013 | 43,43 | 43,89 | 42,91 | 42,92 | -1,51% | 2,26% | 14.772.922 |
| 03/05/2013 | 44,13 | 44,26 | 43,38 | 43,58 | -0,13% | 1,99% | 13.492.581 |
| 02/05/2013 | 43,80 | 43,90 | 43,41 | 43,64 | +0,09% | 1,13% | 14.929.389 |
| 01/05/2013 | 42,75 | 44,19 | 42,56 | 43,60 | -2,79% | 3,82% | 41.648.358 |
| 30/04/2013 | 45,56 | 45,65 | 44,85 | 44,85 | -1,71% | 1,76% | 20.692.446 |
| 29/04/2013 | 45,69 | 45,92 | 45,53 | 45,63 | -0,10% | 0,84% | 11.921.943 |
| 26/04/2013 | 45,11 | 45,87 | 44,95 | 45,68 | +1,10% | 2,03% | 11.110.477 |
| 25/04/2013 | 45,75 | 45,80 | 45,11 | 45,18 | -1,25% | 1,50% | 16.702.081 |
| 24/04/2013 | 46,44 | 46,56 | 45,68 | 45,75 | -1,40% | 1,89% | 16.292.418 |
| 23/04/2013 | 45,75 | 46,47 | 45,73 | 46,40 | +1,48% | 1,61% | 18.500.868 |
| 22/04/2013 | 45,28 | 45,77 | 45,02 | 45,73 | +0,91% | 1,66% | 14.950.139 |
| 19/04/2013 | 44,71 | 45,31 | 44,52 | 45,31 | +2,00% | 1,77% | 13.315.154 |
| 18/04/2013 | 44,71 | 44,83 | 44,36 | 44,43 | -0,43% | 1,05% | 11.813.685 |
| 17/04/2013 | 44,58 | 44,76 | 44,28 | 44,62 | -0,43% | 1,07% | 12.342.506 |
| 16/04/2013 | 44,50 | 44,90 | 44,37 | 44,81 | +1,08% | 1,18% | 10.674.614 |
| 15/04/2013 | 44,74 | 45,32 | 44,33 | 44,33 | -1,38% | 2,22% | 16.083.970 |
| 12/04/2013 | 44,53 | 44,97 | 44,51 | 44,95 | -0,21% | 1,03% | 10.547.491 |
| 11/04/2013 | 44,54 | 45,33 | 44,54 | 45,05 | +0,79% | 1,78% | 18.379.719 |
| 10/04/2013 | 43,81 | 44,82 | 43,68 | 44,69 | +2,92% | 2,59% | 19.634.385 |
| 09/04/2013 | 43,64 | 43,84 | 43,26 | 43,43 | +0,07% | 1,31% | 11.108.066 |
| 08/04/2013 | 43,02 | 43,40 | 42,90 | 43,40 | +0,78% | 1,15% | 10.640.868 |
| 05/04/2013 | 42,98 | 43,16 | 42,83 | 43,06 | -0,42% | 0,75% | 13.206.372 |